NCT00536393
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Clinique Victor Hugo Le Mans, France
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
2,141 public trials
305 recruiting studies
Lymphoma trial results
NCT00320827
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
NCT00169130
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Service d'Hematologie Mont-Godinne, Belgium
- Hôpital Henri Mondor Créteil, France
- Hôpital Saint Louis Paris, France
- Centre Hospitalier Lyon Sud Pierre-Bénite, France
NCT00136552
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium
- Hôpital Henri Mondor Créteil, France
- Hôpital Saint Louis Paris, France
- Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite, France
NCT00086034
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- San Diego, California, United States
- Stanford, California, United States
- Miami, Florida, United States
- Chicago, Illinois, United States
Completed
Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.
NCT00299780
- Conditions
- Acute Myelogenous Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- MD Anderson Cancer Center Houston, Texas, United States
Completed
Dose Reduction in Thoracic CT
NCT00188461
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Toronto General Hospital Toronto, Ontario, Canada
NCT00037791
- Conditions
- Blood Platelet Disorders, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Pfizer Investigational Site Berkeley, California, United States
- Pfizer Investigational Site La Jolla, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
NCT00138086
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium
- Hôpital Henri Mondor Créteil, France
- Hématologie CHU de Lille Lille, France
- Institut Curie Paris, France
NCT00001579
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States